EMEA-001529-PIP02-14-M03
Table of contents
Key facts
| Active substance |
Testosterone
|
| Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
| Decision number |
P/0508/2020
|
| PIP number |
EMEA-001529-PIP02-14-M03
|
| Pharmaceutical form(s) |
Nasal gel
|
| Condition(s) / indication(s) |
Treatment of male hypogonadism
|
| Route(s) of administration |
Nasal use
|
| Contact for public enquiries |
Acerus Biopharma Inc.
Email: fholagh@aceruspharma.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|